MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $176,000 | -12.9% | 61,443 | +204.5% | 0.21% | +14.4% |
| Q3 2018 | $202,000 | +117.2% | 20,180 | +54.0% | 0.19% | +466.7% |
| Q2 2018 | $93,000 | -8.8% | 13,105 | -51.1% | 0.03% | -70.3% |
| Q1 2018 | $102,000 | -32.9% | 26,827 | +43.9% | 0.11% | -40.0% |
| Q4 2017 | $152,000 | +60.0% | 18,643 | +15.1% | 0.18% | +90.7% |
| Q3 2017 | $95,000 | – | 16,198 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|